# A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

> **NCT02902978** · PHASE1 · COMPLETED · sponsor: **EA Pharma Co., Ltd.** · enrollment: 56 (actual)

## Conditions studied

- Japanese Healthy Adult Male Participants

## Interventions

- **DRUG:** E6130
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02902978
- **Lead sponsor:** EA Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-26
- **Primary completion:** 2017-08-17
- **Final completion:** 2017-08-17
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02902978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02902978, "A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02902978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*